Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues

Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues

Abstract Hepatitis D virus (HDV) infection increases the risk of hepatocellular carcinoma (HCC) in the natural course of chronic hepatitis B (CHB) patients. Its role in patients treated with nucleotide/nucleoside analogues (NAs) is unclear. We aimed to study the role of hepatitis D in the developmen...

Full description

Bibliographic Details
Main Authors:	Tyng-Yuan Jang, Yu-Ju Wei, Ta-Wei Liu, Ming-Lun Yeh, Shu-Fen Liu, Cheng-Ting Hsu, Po-Yao Hsu, Yi-Hung Lin, Po-Cheng Liang, Meng-Hsuan Hsieh, Yu-Min Ko, Yi-Shan Tsai, Kuan-Yu Chen, Ching-Chih Lin, Pei-Chien Tsai, Shu-Chi Wang, Ching-I. Huang, Zu-Yau Lin, Shinn-Cherng Chen, Wan-Long Chuang, Jee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang, Ming-Lung Yu
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-04-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-87679-w

Similar Items

Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
by: Tyng-Yuan Jang, et al.
Published: (2021-01-01)

Scaling up the in-hospital hepatitis C virus care cascade in Taiwan
by: Chung-Feng Huang, et al.
Published: (2021-01-01)

Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients.
by: Tyng-Yuan Jang, et al.
Published: (2017-01-01)

Clusters of Circulating let-7 Family Tumor Suppressors Are Associated with Clinical Characteristics of Chronic Hepatitis C
by: Yi-Shan Tsai, et al.
Published: (2020-07-01)

Association of hyperuricemia with disease severity in chronic hepatitis C patients.
by: Tyng-Yuan Jang, et al.
Published: (2018-01-01)

Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan
by: Ming-Ying Lu, et al.
Published: (2021-04-01)

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.
by: Chuan-Pin Lin, et al.
Published: (2021-01-01)

New Nucleoside-and Nucleobase-Coumarin Conjugates as Anti-Hepatitis C Virus Agents
by: Lin, Shu-Yu, et al.
Published: (2010)

The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C
by: Po-Cheng Liang, et al.
Published: (2018-01-01)

The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma.
by: Ming-Lun Yeh, et al.
Published: (2017-01-01)

Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort
by: Ta-Wei Liu, et al.
Published: (2018-01-01)

Host and virological characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection
by: Chung-Feng Huang, et al.
Published: (2015-05-01)

Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment
by: Chung-Feng Huang, et al.
Published: (2017-02-01)

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in chronic hepatitis C patients
by: Ching-I Huang, et al.
Published: (2017-08-01)

Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
by: Po-Yao Hsu, et al.
Published: (2021-01-01)

Virological predictors of response to retreatment in hepatitis C genotype 2 infected patients.
by: Chung-Feng Huang, et al.
Published: (2013-01-01)

Performance characteristics of a combined hepatitis C virus core antigen and anti–hepatitis C virus antibody test in different patient groups
by: Jeng-Fu Yang, et al.
Published: (2011-07-01)

Real‐world effectiveness of direct‐acting antiviral agents for chronic hepatitis C patients with genotype‐2 infection after completed treatment
by: Tzu‐Sheng Cheng, et al.
Published: (2021-04-01)

The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C.
by: Jia-Jung Lee, et al.
Published: (2020-01-01)

Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89]
by: Chung-Feng Huang, et al.
Published: (2017-03-01)

A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan
by: Pei-Chien Tsai, et al.
Published: (2017-01-01)

Cure or curd: Modification of lipid profiles and cardio‐cerebrovascular events after hepatitis C virus eradication
by: Chung‐Feng Huang, et al.
Published: (2020-11-01)

Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection
by: Ta-Ya Lin, et al.
Published: (2017-06-01)

Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection.
by: Hung-Yin Liu, et al.
Published: (2021-01-01)

The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agents
by: Jee-Fu Huang, et al.
Published: (2017-11-01)

Variable uptake feature of focal nodular hyperplasia in Tc-99m phytate hepatic scintigraphy/single-photon emission computed tomography—A parametric analysis
by: Yu-Ling Hsu, et al.
Published: (2015-12-01)

Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
by: Ming-Lun Yeh, et al.
Published: (2015-01-01)

Association between gallbladder stones and chronic hepatitis C: Ultrasonographic survey in a hepatitis C and B hyperendemic township in Taiwan
by: Chia-Yen Dai, et al.
Published: (2013-08-01)

Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients
by: Ming-Yen Hsieh, et al.
Published: (2012-02-01)

Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients.
by: Ming-Lun Yeh, et al.
Published: (2019-01-01)

Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter study
by: Ming-Lun Yeh, et al.
Published: (2016-11-01)

Profile of Nucleotides and Nucleosides in Taiwanese Human Milk
by: Kuo-Yu Liao, et al.
Published: (2011-04-01)

Viral Hepatitis Infections in Southern Taiwan: A Multicenter Community-based Study
by: Jeng-Fu Yang, et al.
Published: (2010-09-01)

Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy
by: Ming‐Lun Yeh, et al.
Published: (2021-02-01)

Paritaprevir/ritonavir/ombitasvir plus dasabuvir with ribavirin for treatment of recurrent chronic hepatitis C genotype 1 infection after liver transplantation: Real-world experience
by: Ming-Lung Yu, et al.
Published: (2018-06-01)

Comparison of Clinical Application of the Abbott HBV PCR Kit and the Versant HBV DNA 3.0 Test to Measure Serum Hepatitis B Virus DNA in Taiwanese Patients
by: Jeng-Fu Yang, et al.
Published: (2009-08-01)

Independent and additive interaction between polymorphisms of tumor necrosis factor α−308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B
by: Jung-Fa Tsai, et al.
Published: (2017-09-01)

Hepatitis C Virus Infection And Metabolic Syndrome—A Community-Based Study in an Endemic Area of Taiwan
by: Jee-Fu Huang, et al.
Published: (2009-06-01)

High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study
by: Tsai Jung-Fa, et al.
Published: (2005-04-01)

Association of response to hepatitis B vaccination and survival in dialysis patients
by: Lin Shih-Yi, et al.
Published: (2012-08-01)